Azitra (AZTR) Return on Invested Capital (2023 - 2026)
Azitra (AZTR) posted Return on Invested Capital of 2.09% for Q1 2026, down 38.36% on a QoQ basis from 1.51% in Q4 2025, and down 115.0% year-over-year from 13.91% in Q1 2025.
Azitra (AZTR) Return on Invested Capital (2023 - 2026) Analysis & Trends
Azitra's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 2.09% for Q1 2026.
- Quarterly Return on Invested Capital fell 115.0% year-over-year to 2.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.09% (down 115.0% YoY) and the FY2025 annual result came in at 6.05%, down 276.0% from the prior year.
- Return on Invested Capital was 2.09% for Q1 2026 at Azitra, down from 1.51% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.73% in Q2 2024 and bottomed at 2.09% in Q1 2026.
- A 4-year average of 1.12% and a median of 1.01% in 2025 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2024 — Return on Invested Capital soared 34 bps — and 2026, when it sank 115 bps.
- Azitra's Return on Invested Capital stood at 1.16% in 2023, then increased by 29 bps to 0.82% in 2024, then tumbled by 84 bps to 1.51% in 2025, then plunged by 38 bps to 2.09% in 2026.
- Business Quant data shows AZTR's Return on Invested Capital at 2.09% in Q1 2026, 1.51% in Q4 2025, and 1.26% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 0.00% |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | 0.04% |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | - |
| 10 | Azitra | 2.05 Mn | 2.05 Mn | - | -2.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.09% |
| Dec 31, 2025 | -1.51% |
| Sep 30, 2025 | -1.26% |
| Jun 30, 2025 | -1.09% |
| Mar 31, 2025 | -0.93% |
| Dec 31, 2024 | -0.82% |
| Sep 30, 2024 | -0.74% |
| Jun 30, 2024 | -0.73% |
| Mar 31, 2024 | -0.86% |
| Dec 31, 2023 | -1.16% |